vs
Global Medical REIT Inc.（GMRE）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Global Medical REIT Inc.的2.0倍（$75.5M vs $38.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 9.2%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 4.6%）
医疗地产信托公司（MPT）是总部位于美国阿拉巴马州伯明翰的国际房地产投资信托基金，主要在美国和欧洲投资收购医疗机构与营利性医疗控股公司。多数收购采用售后回租模式：原业主将物业出售给MPT后转为承租方，租户通常需要签订长期三净租约。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GMRE vs PBYI — 直观对比
营收规模更大
PBYI
是对方的2.0倍
$38.4M
营收增速更快
PBYI
高出18.5%
9.2%
两年增速更快
PBYI
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.4M | $75.5M |
| 净利润 | $-6.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | -16.0% | — |
| 营收同比 | 9.2% | 27.7% |
| 净利润同比 | -309.2% | — |
| 每股收益（稀释后） | $-0.48 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GMREPBYI
| Q4 25 | $38.4M | $75.5M | ||
| Q3 25 | $37.2M | $54.5M | ||
| Q2 25 | $38.0M | $52.4M | ||
| Q1 25 | $34.6M | $46.0M | ||
| Q4 24 | $35.2M | $59.1M | ||
| Q3 24 | $34.3M | $80.5M | ||
| Q2 24 | $34.2M | $47.1M | ||
| Q1 24 | $35.1M | $43.8M |
净利润GMREPBYI
| Q4 25 | $-6.1M | — | ||
| Q3 25 | $-5.1M | $8.8M | ||
| Q2 25 | $585.0K | $5.9M | ||
| Q1 25 | $3.7M | $3.0M | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $3.4M | $20.3M | ||
| Q2 24 | $-2.0M | $-4.5M | ||
| Q1 24 | $2.3M | $-4.8M |
毛利率GMREPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率GMREPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率GMREPBYI
| Q4 25 | -16.0% | — | ||
| Q3 25 | -13.6% | 16.2% | ||
| Q2 25 | 1.5% | 11.2% | ||
| Q1 25 | 10.8% | 6.5% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 9.9% | 25.2% | ||
| Q2 24 | -5.7% | -9.6% | ||
| Q1 24 | 6.6% | -11.0% |
每股收益（稀释后）GMREPBYI
| Q4 25 | $-0.48 | $0.26 | ||
| Q3 25 | $-0.45 | $0.17 | ||
| Q2 25 | $-0.01 | $0.12 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $-0.04 | $0.40 | ||
| Q3 24 | $0.14 | $0.41 | ||
| Q2 24 | $-0.05 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.1M | $97.5M |
| 总债务越低越好 | $1.2M | $22.7M |
| 股东权益账面价值 | $509.8M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GMREPBYI
| Q4 25 | $9.1M | $97.5M | ||
| Q3 25 | $7.1M | $94.4M | ||
| Q2 25 | $6.6M | $96.0M | ||
| Q1 25 | $5.4M | $93.2M | ||
| Q4 24 | $6.8M | $101.0M | ||
| Q3 24 | $5.7M | $96.7M | ||
| Q2 24 | $5.0M | $96.8M | ||
| Q1 24 | $1.3M | $107.2M |
总债务GMREPBYI
| Q4 25 | $1.2M | $22.7M | ||
| Q3 25 | $1.2M | $34.0M | ||
| Q2 25 | $14.2M | $45.3M | ||
| Q1 25 | $14.3M | $56.7M | ||
| Q4 24 | $14.4M | $68.0M | ||
| Q3 24 | $14.5M | $79.3M | ||
| Q2 24 | $14.7M | $90.7M | ||
| Q1 24 | $25.7M | $102.0M |
股东权益GMREPBYI
| Q4 25 | $509.8M | $130.3M | ||
| Q3 25 | $485.3M | $115.3M | ||
| Q2 25 | $503.2M | $104.7M | ||
| Q1 25 | $517.4M | $97.1M | ||
| Q4 24 | $534.1M | $92.1M | ||
| Q3 24 | $542.6M | $71.1M | ||
| Q2 24 | $556.4M | $48.5M | ||
| Q1 24 | $575.0M | $51.0M |
总资产GMREPBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.3B | $194.9M | ||
| Q1 25 | $1.3B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.2B | $220.7M | ||
| Q2 24 | $1.2B | $205.0M | ||
| Q1 24 | $1.3B | $214.1M |
负债/权益比GMREPBYI
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.03× | 0.43× | ||
| Q1 25 | 0.03× | 0.58× | ||
| Q4 24 | 0.03× | 0.74× | ||
| Q3 24 | 0.03× | 1.12× | ||
| Q2 24 | 0.03× | 1.87× | ||
| Q1 24 | 0.04× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流GMREPBYI
| Q4 25 | $73.6M | $14.4M | ||
| Q3 25 | $17.6M | $9.7M | ||
| Q2 25 | $22.1M | $14.1M | ||
| Q1 25 | $12.3M | $3.6M | ||
| Q4 24 | $70.0M | $15.6M | ||
| Q3 24 | $16.3M | $11.0M | ||
| Q2 24 | $18.9M | $1.0M | ||
| Q1 24 | $14.3M | $11.2M |
自由现金流GMREPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率GMREPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度GMREPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率GMREPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 37.84× | 2.41× | ||
| Q1 25 | 3.28× | 1.21× | ||
| Q4 24 | 23.83× | — | ||
| Q3 24 | 4.81× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
